Yan Li to Diabetic Nephropathies
This is a "connection" page, showing publications Yan Li has written about Diabetic Nephropathies.
Connection Strength
2.220
-
ATP-citrate lyase is essential for high glucose-induced histone hyperacetylation and fibrogenic gene upregulation in mesangial cells. Am J Physiol Renal Physiol. 2017 Aug 01; 313(2):F423-F429.
Score: 0.496
-
Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. J Am Soc Nephrol. 2012 Dec; 23(12):1977-86.
Score: 0.363
-
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int. 2010 Jun; 77(11):1000-9.
Score: 0.301
-
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009 Sep; 297(3):F791-801.
Score: 0.287
-
Vitamin D and diabetic nephropathy. Curr Diab Rep. 2008 Dec; 8(6):464-9.
Score: 0.277
-
Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15896-901.
Score: 0.274
-
Podocytes as target of vitamin D. Curr Diabetes Rev. 2011 Jan; 7(1):35-40.
Score: 0.080
-
Renoprotective effects of vitamin D analogs. Kidney Int. 2010 Jul; 78(2):134-9.
Score: 0.072
-
1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway. Am J Physiol Renal Physiol. 2009 May; 296(5):F1212-8.
Score: 0.070